CRBP Dividend: Corbus Pharmaceuticals Holdings Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	3
Revenue Growth (YoY)	--	--	--	--	-100%	-92%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	15	16	14	18	20	28
Research & Development	60	--	31	16	36	98
Operating Expenses	75	49	45	34	56	126
Other Non Operating Income (Expenses)	0	9	3	0	11	13
Pretax Income	-67	-40	-45	-42	-45	-111
Income Tax Expense	--	--	--	--	--	--
Net Income	-67	-40	-45	-42	-45	-111
Net Income Growth	76%	-11%	7%	-7%	-59%	56%
Shares Outstanding (Diluted)	12.3	11	4.33	4.17	4.1	2.6
Shares Change (YoY)	2%	154%	4%	2%	57.99%	22%
EPS (Diluted)	-5.48	-3.63	-10.39	-10.15	-11.13	-42.79
EPS Growth	70%	-65%	2%	-9%	-74%	28%
Free Cash Flow	-59	-41	-36	-37	-48	-100
Free Cash Flow Per Share	-4.79	-3.72	-8.31	-8.87	-11.7	-38.46
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	-4,066.66%
Profit Margin	0%	0%	0%	0%	0%	-3,700%
Free Cash Flow Margin	0%	0%	0%	0%	0%	-3,333.33%
EBITDA	-75	-49	-45	-34	-54	-121
EBITDA Margin	0%	0%	0%	0%	0%	-4,033.33%
D&A For EBITDA	0	0	0	0	1	1
EBIT	-75	-49	-45	-34	-55	-122
EBIT Margin	0%	0%	0%	0%	0%	-4,066.66%
Effective Tax Rate	--	--	--	--	--	--

Corbus Pharmaceuticals Holdings Inc (CRBP) Price